Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
Wenjuan Di, Haotian Xu, Ting Xue, Chunhua Ling Department of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, Suzhou City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Chunhua LingDepartment of Respiratory and Critical Care Medicine, The Fir...
Guardado en:
Autores principales: | Di W, Xu H, Xue T, Ling C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9efe58bd40d42cf84e2fa08a61f003c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer
por: Wei Xiong, et al.
Publicado: (2021) -
Systematic review of the venous thromboembolism risk assessment models used in aesthetic plastic surgery
por: Amelia J. White, et al.
Publicado: (2021) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021) -
Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis
por: Antonella Tufano, et al.
Publicado: (2021)